Scholarlink

<p>Hemorrhagic stroke (HS) is a life-threatening condition with high mortality, particularly in intensive care unit (ICU) settings. The serum creatinine-to-albumin ratio (CAR) has emerged as a novel biomarker integrating renal dysfunction and systemic inflammation, but its prognostic value in HS remains underexplored. This retrospective cohort study analyzed data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. We included 1,046 adult ICU patients with HS (intracerebral or subarachnoid hemorrhage) and stratified them by CAR quartiles. The primary outcome was 28-day all-cause mortality (ACM). Multivariable Cox regression models adjusted for age, Glasgow Coma Scale (GCS) score, and comorbidities were used to assess associations. Predictive performance was evaluated using receiver operating characteristic (ROC) curves and restricted cubic spline (RCS) analysis. The 28-day mortality increased significantly across CAR quartiles (Q1-Q4: 21.8%, 19.1%, 36.0%, and 40.8%, respectively;&#xa0;<i>P</i>&#xa0;for trend &lt; 0.001). In the fully adjusted model (Model 3), patients in the highest CAR quartile (Q4) had a 2.30-fold higher mortality risk (95% CI: 1.58–3.35;&#xa0;<i>P</i> &lt; 0.001) compared to Q1. CAR demonstrated significantly higher discriminative ability (AUC = 0.612, 95% CI: 0.574–0.650) compared to isolated creatinine (AUC = 0.568) or albumin (AUC = 0.371) measurements (<i>P</i> &lt; 0.01). RCS analysis revealed a nonlinear relationship, with CAR &gt; 0.25 marking a critical threshold for increased mortality risk. CAR is an independent predictor of 28-day mortality in critically ill patients with HS, outperforming traditional single biomarkers. Its clinical accessibility and robust prognostic performance suggest potential utility for early risk stratification and personalized treatment strategies in HS management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Serum creatinine-to-albumin ratio predicts mortality in hemorrhagic stroke: a novel threshold for risk stratification

  • 期刊论文

  • 发表日期：

    2025年5月21日

查看全文
  • Shuwen Sun,
  • Xiaobin Fei,
  • Xin Huang,
  • Kai Gong

摘要

Hemorrhagic stroke (HS) is a life-threatening condition with high mortality, particularly in intensive care unit (ICU) settings. The serum creatinine-to-albumin ratio (CAR) has emerged as a novel biomarker integrating renal dysfunction and systemic inflammation, but its prognostic value in HS remains underexplored. This retrospective cohort study analyzed data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. We included 1,046 adult ICU patients with HS (intracerebral or subarachnoid hemorrhage) and stratified them by CAR quartiles. The primary outcome was 28-day all-cause mortality (ACM). Multivariable Cox regression models adjusted for age, Glasgow Coma Scale (GCS) score, and comorbidities were used to assess associations. Predictive performance was evaluated using receiver operating characteristic (ROC) curves and restricted cubic spline (RCS) analysis. The 28-day mortality increased significantly across CAR quartiles (Q1-Q4: 21.8%, 19.1%, 36.0%, and 40.8%, respectively; P for trend < 0.001). In the fully adjusted model (Model 3), patients in the highest CAR quartile (Q4) had a 2.30-fold higher mortality risk (95% CI: 1.58–3.35; P < 0.001) compared to Q1. CAR demonstrated significantly higher discriminative ability (AUC = 0.612, 95% CI: 0.574–0.650) compared to isolated creatinine (AUC = 0.568) or albumin (AUC = 0.371) measurements (P < 0.01). RCS analysis revealed a nonlinear relationship, with CAR > 0.25 marking a critical threshold for increased mortality risk. CAR is an independent predictor of 28-day mortality in critically ill patients with HS, outperforming traditional single biomarkers. Its clinical accessibility and robust prognostic performance suggest potential utility for early risk stratification and personalized treatment strategies in HS management.